MiMedx Group Analyst Ratings
MiMedx Group Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/02/2023 | 38.71% | HC Wainwright & Co. | $8 → $11 | Maintains | Buy |
| 06/21/2023 | 0.88% | HC Wainwright & Co. | $9.5 → $8 | Maintains | Buy |
| 05/03/2023 | 19.8% | HC Wainwright & Co. | $8 → $9.5 | Maintains | Buy |
| 03/02/2023 | 0.88% | HC Wainwright & Co. | → $8 | Reiterates | → Buy |
| 10/13/2022 | -11.73% | Mizuho | → $7 | Initiates Coverage On | → Buy |
| 09/07/2022 | 0.88% | HC Wainwright & Co. | $8.5 → $8 | Maintains | Buy |
| 09/14/2021 | 7.19% | HC Wainwright & Co. | $20 → $8.5 | Maintains | Buy |
| 07/26/2021 | 190.04% | Northland Capital Markets | → $23 | Initiates Coverage On | → Outperform |
| 03/19/2021 | 152.21% | HC Wainwright & Co. | → $20 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 08/02/2023 | 38.71% | HC Wainwright公司 | $8→$11 | 維護 | 買 |
| 2023年6月21日 | 0.88% | HC Wainwright公司 | $9.5→$8 | 維護 | 買 |
| 05/03/2023 | 19.8% | HC Wainwright公司 | $8→$9.5 | 維護 | 買 |
| 03/02/2023 | 0.88% | HC Wainwright公司 | →$8 | 重申 | →購買 |
| 10/13/2022 | -11.73% | 瑞穗 | →$7 | 開始承保 | →購買 |
| 09/07/2022 | 0.88% | HC Wainwright公司 | $8.5→$8 | 維護 | 買 |
| 09/14/2021 | 7.19% | HC Wainwright公司 | $20→$8.5 | 維護 | 買 |
| 07/26/2021 | 190.04% | 北國資本市場 | →$23 | 開始承保 | →跑贏大盤 |
| 03/19/2021 | 152.21% | HC Wainwright公司 | →$20 | 開始承保 | →購買 |
What is the target price for MiMedx Group (MDXG)?
MiMedx Group(MDXG)的目標價是多少？
The latest price target for MiMedx Group (NASDAQ: MDXG) was reported by HC Wainwright & Co. on August 2, 2023. The analyst firm set a price target for $11.00 expecting MDXG to rise to within 12 months (a possible 38.71% upside). 6 analyst firms have reported ratings in the last year.
HC Wainwright&Co.於2023年8月2日報道了MiMedx集團(納斯達克代碼：MDXG)的最新目標價。這家分析公司將MDXG的目標價設定為11.00美元，預計MDXG將在12個月內上漲(可能上漲38.71%)。6家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for MiMedx Group (MDXG)?
MiMedx Group(MDXG)的最新分析師評級是什麼？
The latest analyst rating for MiMedx Group (NASDAQ: MDXG) was provided by HC Wainwright & Co., and MiMedx Group maintained their buy rating.
分析師對MiMedx Group(納斯達克代碼：MDXG)的最新評級由HC Wainwright&Co.提供，MiMedx Group維持買入評級。
When is the next analyst rating going to be posted or updated for MiMedx Group (MDXG)?
MiMedx Group(MDXG)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MiMedx Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MiMedx Group was filed on August 2, 2023 so you should expect the next rating to be made available sometime around August 2, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與MiMedx集團的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。MiMedx集團的上一次評級是在2023年8月2日提交的，所以你應該預計下一次評級將在2024年8月2日左右的某個時候公佈。
Is the Analyst Rating MiMedx Group (MDXG) correct?
分析師對MiMedx Group(MDXG)的評級正確嗎？
While ratings are subjective and will change, the latest MiMedx Group (MDXG) rating was a maintained with a price target of $8.00 to $11.00. The current price MiMedx Group (MDXG) is trading at is $7.93, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的MiMedx Group(MDXG)評級維持不變，目標價在8.00美元至11.00美元之間。MiMedx Group目前的交易價格為7.93美元，超出了分析師的預測區間。